Internal Medicine, Rheumatology · Dallas, TX
NPI
1295114254
Since 2015
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5200 Harry Hines Blvd
Dallas, TX, 75235
Phone (214) 590-4656
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,826
189 services
Medicare patients, 2024
113
Average age 63
Drug cost, 2024
$2.0M
1,220 prescriptions
Company payments, 2024
$622
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria A Bacalao was code 99214 (office e&m - established), 121 times for 91 patients. In total Maria A Bacalao billed 189 services in 8 codes, and Medicare paid $9,826.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 121 | 91 | $59.59 | $7,211 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 38 | 38 | $12.50 | $475 |
| 99204 Office E&M - New | Facility | 13 | 13 | $95.80 | $1,245 |
By year: 2022 $8,906 for 139 services; 2023 $5,657 for 94 services; 2024 $9,826 for 189 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria A Bacalao prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 97 prescriptions and refills. In total Maria A Bacalao wrote 1,220 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 97 | 234 | 44 | $5,022 |
| Methotrexate Methotrexate Sodium | 89 | 201 | 36 | $1,991 |
| Humira Adalimumab | 84 | 97 | 16 | $726K |
| Prednisone Generic | 70 | 100 | 29 | $395 |
| Leflunomide Generic | 67 | 172 | 31 | $4,683 |
| Enbrel Etanercept | 46 | 50 | Under 11 | $349K |
| Sulfasalazine Generic | 41 | 92 | 19 | $1,659 |
| Mycophenolate Mofetil Generic | 38 | 75 | 15 | $6,289 |
| Cyclobenzaprine Hcl Generic | 38 | 65 | 16 | $797 |
| Meloxicam Generic | 32 | 63 | 16 | $111 |
| Pantoprazole Sodium Generic | 31 | 73 | 14 | $293 |
| Naproxen Generic | 30 | 47 | 12 | $455 |
| Folic Acid Generic | 29 | 82 | 12 | $173 |
| Duloxetine Hcl Generic | 24 | 50 | Under 11 | $455 |
| Azathioprine Generic | 24 | 59 | 12 | $1,756 |
Brand drugs: 286 claims; generic drugs: 934 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Maria A Bacalao $622 ($622 in general payments such as food, travel and fees) from 2 companies. The largest payer was GlaxoSmithKline, LLC. with $488.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.